SHOX2B, a variant of the SHOX2 gene, is an intriguing subject within the field of genetic research. SHOX2, which is known for its role in embryonic development, particularly in the formation of the limbs and the heart, is an example of a homeobox gene that encodes a transcription factor pivotal for normal skeletal development. The expression of SHOX2 is intricately regulated at multiple levels, including transcriptional, post-transcriptional, and epigenetic mechanisms. This complex regulation allows for the proper spatial and temporal expression patterns that are essential for organismal development. The potential variant SHOX2B, by extension, would be presumed to share similar regulatory elements and developmental roles. Understanding the regulatory mechanisms behind SHOX2B expression is not only fundamental to developmental biology but also to advancing the knowledge of gene expression modulation.
In the context of gene expression modulation, a variety of chemical compounds have been identified that can potentially induce the expression of genes like SHOX2B. These chemical activators operate through diverse pathways to promote gene expression. For instance, compounds such as retinoic acid and tretinoin are known to bind to retinoic acid receptors, activating genes essential for developmental processes. Other chemicals, like forskolin, can raise intracellular cAMP levels, which in turn activate protein kinase A and lead to the phosphorylation of transcription factors that encourage the expression of target genes, including those involved in developmental pathways. Epigenetic modifiers such as 5-Azacytidine and Trichostatin A work by altering the chromatin structure around gene promoters-5-Azacytidine by reducing methylation levels, and Trichostatin A by inhibiting histone deacetylases, which results in increased acetylation and a more transcriptionally active chromatin state. These and other compounds, such as the histone deacetylase inhibitors sodium butyrate and valproic acid, enhance the accessibility of transcription factors to the DNA, facilitating the transcription of genes involved in critical developmental processes. Through the strategic study of these compounds and their mechanisms of action, scientists can gain a deeper understanding of the regulatory networks that govern the expression of essential genes like SHOX2B.
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic acid may upregulate SHOX2B expression by binding to retinoic acid receptors, which can initiate transcriptional changes, specifically increasing the transcriptional activity of genes involved in limb and heart development. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine could stimulate SHOX2B expression by causing hypomethylation of gene promoters, thereby facilitating the transcription of genes that are typically silenced by methylation, including those critical for developmental pathways. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A may increase the expression of SHOX2B by inhibiting histone deacetylases, leading to enhanced acetylation near gene regulatory regions and stimulating the initiation of transcription in genes governing developmental processes. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin could potentially induce SHOX2B expression by elevating intracellular cAMP levels, which in turn activate protein kinase A (PKA) and subsequently phosphorylate transcription factors that stimulate the expression of target genes. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride may stimulate SHOX2B expression by activating the Wnt/beta-catenin signaling pathway, which is known to upregulate genes that are essential for the proper development of embryonic structures. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $62.00 $178.00 | 8 | |
β-Estradiol could potentially upregulate SHOX2B expression through the estrogen receptor pathway, which, upon activation, binds to DNA sequences and increases transcription of genes involved in sexual differentiation and development. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $76.00 $82.00 $367.00 | 36 | |
Dexamethasone may induce SHOX2B expression by activating glucocorticoid receptors, which can lead to the binding of these receptors to glucocorticoid response elements in the DNA, increasing transcription of developmental genes. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
Sodium butyrate could increase SHOX2B transcription by inhibiting histone deacetylation, which results in a more relaxed chromatin structure, enhancing accessibility for transcription machinery to developmental gene promoters. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
Valproic acid might stimulate SHOX2B expression by inhibiting histone deacetylase, thereby increasing acetylation levels of histones associated with the SHOX2B gene, leading to an upsurge in gene transcription. | ||||||
Folic Acid | 59-30-3 | sc-204758 | 10 g | $72.00 | 2 | |
Folic acid could potentially upregulate SHOX2B expression through its role in generating S-adenosylmethionine, a key methyl donor for methylation reactions, which could alter epigenetic marks and promote gene transcription. |